The manner in which calories are restricted impacts mammary tumor cancer prevention
- PMID: 22013391
- PMCID: PMC3190408
- DOI: 10.4103/1477-3163.85181
The manner in which calories are restricted impacts mammary tumor cancer prevention
Abstract
Although treatments for breast cancer have improved and long-term survival after diagnosis is now common, prevention of the disease is the ultimate goal. Weight loss or weight maintenance is one approach that has been recommended to reduce the risk of breast cancer, particularly for peri/postmenopausal women. This approach is supported by decades of data indicating that calorie restriction prevents spontaneous and chemically induced mammary tumor development in rodents. In most cases, calorie restriction was implemented by a consistent daily reduction of calories, i.e. chronic calorie restriction (CCR). There have also been several studies where periods of reduced caloric intake were followed by periods of refeeding, i.e. intermittent calorie restriction (ICR), resulting in the prevention of spontaneous mammary tumorigenesis. In most of the early studies, there were no direct comparisons of CCR to ICR. One study using moderate calorie restriction in a chemically induced breast cancer rat model found a slight increase in mammary tumor incidence compared with ad libitum fed and CCR rats. However, recently, it has been demonstrated in several transgenic mouse models of breast cancer that ICR consistently provided a greater degree of protection than CCR. This review will provide a detailed comparison of ICR and CCR for breast cancer prevention. It will also examine potential mechanisms of action that may include periods of reduced IGF-I and leptin as well as an increase in the adiponectin:leptin ratio. Application of this approach to at-risk women may provide an approach to lower the risk of breast cancer in overweight/obese women.
Keywords: Animal models; breast cancer; calorie restriction; intermittent calorie restriction.
Figures

Similar articles
-
The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding.Breast Cancer Res Treat. 2013 Apr;138(2):395-406. doi: 10.1007/s10549-013-2464-7. Epub 2013 Feb 28. Breast Cancer Res Treat. 2013. PMID: 23446811 Free PMC article.
-
Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages.Oncol Lett. 2010 Jan;1(1):167-176. doi: 10.3892/ol_00000031. Epub 2010 Jan 1. Oncol Lett. 2010. PMID: 22966277 Free PMC article.
-
Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response?Exp Biol Med (Maywood). 2007 Jan;232(1):70-80. Exp Biol Med (Maywood). 2007. PMID: 17202587
-
Calorie restriction, ad libitum feeding, and cancer.Proc Soc Exp Biol Med. 1986 Dec;183(3):293-8. Proc Soc Exp Biol Med. 1986. PMID: 3025885 Review.
-
Weight reduction for breast cancer prevention by restriction of dietary fat and calories: rationale, mechanisms and interventions.Nutrition. 1989 May-Jun;5(3):149-54. Nutrition. 1989. PMID: 2520282 Review.
Cited by
-
Medicinal chemistry of the epigenetic diet and caloric restriction.Curr Med Chem. 2013;20(32):4050-9. doi: 10.2174/09298673113209990189. Curr Med Chem. 2013. PMID: 23895687 Free PMC article. Review.
-
Employing proteomics to understand the effects of nutritional intervention in cancer treatment.Anal Bioanal Chem. 2018 Oct;410(25):6371-6386. doi: 10.1007/s00216-018-1219-z. Epub 2018 Jul 4. Anal Bioanal Chem. 2018. PMID: 29974151 Free PMC article. Review.
-
Maternal caloric restriction partially rescues the deleterious effects of advanced maternal age on offspring.Aging Cell. 2014 Aug;13(4):623-30. doi: 10.1111/acel.12217. Epub 2014 Mar 24. Aging Cell. 2014. PMID: 24661622 Free PMC article.
-
Transcriptome Analysis of the Thymus in Short-Term Calorie-Restricted Mice Using RNA-seq.Int J Genomics. 2018 Feb 4;2018:7647980. doi: 10.1155/2018/7647980. eCollection 2018. Int J Genomics. 2018. PMID: 29511668 Free PMC article.
-
Managing Metastatic Thymoma With Metabolic and Medical Therapy: A Case Report.Front Oncol. 2020 May 5;10:578. doi: 10.3389/fonc.2020.00578. eCollection 2020. Front Oncol. 2020. PMID: 32457832 Free PMC article.
References
-
- Kiely BE, Soon YY, Tattersall MH, Stockler MR. How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials. J Clin Oncol. 2011;29:456–63. - PubMed
-
- Gulati AP, Domchek SM. The clinical management of BRCA1 and BRCA2 mutation carriers. Curr Oncol Rep. 2008;10:47–53. - PubMed
-
- Tirona MT, Sehgal R, Ballester O. Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools. Cancer Invest. 2010;28:743–50. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources